Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia

Antiviral Therapy

Volumn 16, Issue 2, 2011, Pages 237-247

  Lee, Nelson ^a,b   Chan, Paul K S ^b   Wong, Chun Kwok ^b   Wong, Ka Tak ^b   Choi, Kin Wing ^b   Joynt, Gavin M ^b   Lam, Philip ^b   Chan, Martin C W ^a   Wong, Bonnie C K ^a   Lui, Grace C Y ^a   Sin, Winnie W Y ^b   Wong, Rity Y K ^a   Lam, Wai Yip ^b   Yeung, Apple C M ^b   Leung, Ting Fan ^b   So, Hing Yu ^b   Yu, Alex W Y ^b   Sung, Joseph J Y ^a,b   Hui, David S C ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OSELTAMIVIR; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; VIRUS RNA;

2009 H1N1 INFLUENZA; ADULT; AGE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; FECES ANALYSIS; FEMALE; GENE MUTATION; HOSPITAL PATIENT; HUMAN; HYPOXEMIA; INFLAMMATION; INFLUENZA VIRUS A H1N1; LOWER RESPIRATORY TRACT; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNGEAL ASPIRATION; NOSE SMEAR; OBSERVATIONAL STUDY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REBOUND; RESPIRATORY TRACT INTUBATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; THROAT CULTURE; TRACHEAL ASPIRATION PROCEDURE; URINALYSIS; VIRAL CLEARANCE; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CYTOKINES; FEMALE; HOSPITALIZATION; HUMANS; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NASOPHARYNX; PANDEMICS; PNEUMONIA, VIRAL; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; TRACHEA; YOUNG ADULT;

EID: 79953230465     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1722     Document Type: Article

References (44)

1. World Health Organization. Pandemic (H1N1) 2009 - update 94. (Accessed 31 May 2010.) Available from http://www.who.int/csr/don/2010-04-01/en/index.html
2. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:1708-1719.
3. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; 374:2072-2079.
4. US Centers for Disease Control and Prevention. H1N1 Flu. Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009 - April 10, 2010. (Accessed 31 May 2010.) Available from http://www.cdc.gov/h1n1flu/estimates-2009-h1n1.htm
5. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-1944.
6. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302:1880-1887.
7. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872-1879.
8. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:1896-1902.
9. The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361:1925-1934.
10. Rello J, Rodriguez A, Ibanez P, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 2009; 13:R148.
11. Zarychanski R, Stuart TL, Kumar A, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010; 182:257-264.
12. Campbell A, Rodin R, Kropp R, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010; 182:349-355.
13. World Health Organization. Clinical management of human infection with pandemic (H1N1) 2009. (Updated November 2009. Accessed 31 May 2010.) Available from http://www.who.int/csr/resources/publications/swineflu/clinical-management- h1n1.pdf
14. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1003-1032.
15. Lee N, Choi KW, Chan PK, et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010; 65:510-515.
16. Lee N, Chan PKS, Choi KW, et al. Factors associated with early hospital discharge of adult influenza patients. Antivir Ther 2007; 12:501-508. (Pubitemid 47041148)
17. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009; 200:492-500.
18. Lee N, Wong CK, Chan PK, et al. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin Infect Dis 2007; 45:723-731. (Pubitemid 47378886)
19. Lam WY, Leung TF, Lee N, et al. Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus. J Med Virol 2010; 82:675-683.
20. Hospital Authority, Hong Kong SAR. Clinical guidelines and protocols by HAHO. (Accessed 1 December 2009.) Available from http://www.ha.org.hk/visitor/ ha-visitor-index.asp?Parent-ID=138537&Content-ID=138667
21. Chan MC, Lee N, Chan PK, Leung TF, Sung JJ. Fecal detection of influenza A virus in patients with concurrent respiratory and gastrointestinal symptoms. J Clin Virol 2009; 45:208-211.
22. Ngai KL, Lam WY, Lee N, Leung TF, Hui DS, Chan PK. Allele-specific conventional reverse-transcription polymerase chain reaction as a screening assay for discriminating influenza a H1N1 (H275Y) oseltamivir-resistant and wild-type viruses. J Med Virol 2010; 82:1295-1298.
23. Wong KT, Antonio GE, Hui DS, et al. Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. Radiology 2003; 228:401-406. (Pubitemid 36910078)
24. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-1952.
25. + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci U S A 2010; 107:12599-12604.
26. Cao B, Li XW, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009; 361:2507-2517.
27. Witkop CT, Duffy MR, Macias EA, et al. Novel influenza A (H1N1) outbreak at the US Air Force Academy: epidemiology and viral shedding duration. Am J Prev Med 2010; 38:121-126.
28. De Serres G, Rouleau I, Hamelin ME, et al. Contagious period for pandemic (H1N1) 2009. Emerg Infect Dis 2010; 16:783-788.
29. Ling LM, Chow AL, Lye DC, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010; 50:963-969.
30. Munster VJ, de Wit E, van den Brand JM, et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 2009; 325:481-483.
31. Maines TR, Jayaraman A, Belser JA, et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009; 325:484-487.
32. Chan MC, Chan RW, Yu WC, et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 2010; 176:1828-1840.
33. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009; 460:1021-1025.
34. Leekha S, Zitterkopf NL, Espy MJ, Smith TF, Thompson RL, Sampathkumar P. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007; 28:1071-1076. (Pubitemid 47345268)
35. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009; 13:R201.
36. To KK, Hung IF, Li IW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010; 50:850-859.
37. Li IW, Hung IF, To KK, et al. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest 2010; 137:759-768.
38. Yeh E, Luo RF, Dyner L, et al. Preferential lower respiratory tract infection in swine-origin 2009 A(H1N1) influenza. Clin Infect Dis 2010; 50:391-394.
39. Fleury H, Burrel S, Weber CB, et al. Prolonged shedding of influenza A(H1N1) virus: two case reports from France. Euro Surveill 2009; 14:19434.
40. World Health Organization. Infection prevention and control in health care for confirmed or suspected cases of pandemic (H1N1) 2009 and influenza-like illnesses. (Updated 16 December 2009. Accessed 17 June 2010.) Available from http://www.who.int/csr/resources/publications/swineflu/swineinfinfcont/en/index. html
41. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12:1203-1207. (Pubitemid 44527358)
42. Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis 2009; 48 Suppl 1:S3-S13.
43. Birnkrant D, Cox E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 2009; 361:2204-2207.
44. Tramontana AR, George B, Hurt AC, et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 2010; 16:1068-1075.